<section class="slide" data-slide-id="S43">

  <!-- HEADER -->
  <div style="margin-bottom: 1.6vw;">
    <div class="label-gold" style="margin-bottom: 0.55vw;">THREAD 3 — SAMS + BEMPEDOIC</div>
    <h2 style="margin-bottom: 0.55vw;">SAMS: quando o sintoma vira risco</h2>
    <div class="lead" style="max-width: 92%;">
      Se rotulamos “intolerância” sem testar causalidade, perdemos benefício cardiovascular evitável.
    </div>
  </div>

  <!-- LAYOUT -->
  <div style="display: grid; grid-template-columns: 1.55fr 1fr; gap: 2.0vw; flex-grow: 1; align-items: start;">

    <!-- LEFT COLUMN -->
    <div style="display: flex; flex-direction: column; gap: 1.15vw;">

      <div class="card" style="padding: 1.35vw;">
        <div class="small-title">Definição operacional (SAMS)</div>

        <div style="margin-top: 0.85vw; display: grid; gap: 0.55vw; font-size: 1.05vw; line-height: 1.35; color: var(--text);">
          <div class="bulletRow"><span class="iconCircle iconCircle--teal">✓</span><span>Sintoma <b>inicia/piora</b> com estatina</span></div>
          <div class="bulletRow"><span class="iconCircle iconCircle--teal">✓</span><span>Melhora com <b>dechallenge</b></span></div>
          <div class="bulletRow"><span class="iconCircle iconCircle--teal">✓</span><span>Reaparece com <b>rechallenge</b> (quando seguro)</span></div>
        </div>

        <div class="note" style="margin-top: 0.95vw; border-left-color: var(--gold); background: rgba(var(--gold-rgb),0.10);">
          <p style="margin:0; font-size: 1.02vw; line-height: 1.4; color: var(--navy);">
            <b>Regra mental:</b> SAMS ≠ causalidade. Causalidade se demonstra.
          </p>
        </div>
      </div>

      <div class="card" style="padding: 1.35vw;">
        <div class="small-title">Por que importa?</div>

        <div style="margin-top: 0.95vw; display:grid; grid-template-columns: 1fr 1fr; gap: 1.25vw; align-items: stretch;">
          <div style="border: 1px solid var(--border); border-radius: 0.9vw; padding: 1.05vw; text-align:center;">
            <div style="font-size: 0.82vw; color: var(--muted); text-transform: uppercase; letter-spacing: 0.08em; font-weight: 900;">Prevalência</div>
            <div style="margin-top: 0.35vw; font-family: var(--font-serif); font-size: 3.2vw; font-weight: 800; color: var(--navy); line-height: 1;">10–25%</div>
            <div style="margin-top: 0.4vw; font-size: 0.95vw; color: var(--muted);">em usuários de estatina (relato)</div>
          </div>

          <div style="border: 1px solid var(--border); border-radius: 0.9vw; padding: 1.05vw; text-align:center; background: rgba(var(--navy-rgb),0.02);">
            <div style="font-size: 0.82vw; color: var(--muted); text-transform: uppercase; letter-spacing: 0.08em; font-weight: 900;">Impacto</div>
            <div style="margin-top: 0.35vw; font-family: var(--font-serif); font-size: 3.2vw; font-weight: 800; color: var(--navy); line-height: 1;">~60%</div>
            <div style="margin-top: 0.4vw; font-size: 0.95vw; color: var(--muted);">ex‑usuários relatam sintomas</div>
          </div>
        </div>

        <div style="margin-top: 0.95vw; font-size: 1.02vw; line-height: 1.4; color: var(--muted);">
          O risco está em <b>parar sem testar</b>: perder redução de eventos por medo/atribuição incorreta.
        </div>
      </div>

    </div>

    <!-- RIGHT COLUMN -->
    <div style="display: flex; flex-direction: column; gap: 1.15vw;">

      <div class="card bg-navy" style="padding: 1.35vw; border: 1px solid rgba(255,255,255,0.14);">
        <div style="font-size: 0.82vw; color: rgba(255,255,255,0.75); text-transform: uppercase; letter-spacing: 0.10em; font-weight: 900;">Espectro de gravidade</div>

        <div style="margin-top: 0.9vw; display: grid; gap: 0.8vw;">
          <div style="padding: 0.85vw 0.9vw; border-radius: 0.9vw; background: rgba(255,255,255,0.06); border: 1px solid rgba(255,255,255,0.12);">
            <div style="display:flex; justify-content:space-between; gap: 0.8vw; align-items:baseline;">
              <div style="font-size: 1.05vw; font-weight: 900; color: rgba(255,255,255,0.95);">Mialgia (maioria)</div>
              <span class="chip chip--teal" style="background: rgba(var(--teal-rgb),0.22); border-color: rgba(var(--teal-rgb),0.30); color: rgba(255,255,255,0.92);">retestar</span>
            </div>
            <div style="margin-top: 0.35vw; font-size: 0.95vw; line-height: 1.35; color: rgba(255,255,255,0.78);">Dor/cãibras, CK normal</div>
          </div>

          <div style="padding: 0.85vw 0.9vw; border-radius: 0.9vw; background: rgba(255,255,255,0.06); border: 1px solid rgba(255,255,255,0.12);">
            <div style="display:flex; justify-content:space-between; gap: 0.8vw; align-items:baseline;">
              <div style="font-size: 1.05vw; font-weight: 900; color: rgba(255,255,255,0.95);">Miopatia (raro)</div>
              <span class="chip chip--gold" style="background: rgba(var(--gold-rgb),0.22); border-color: rgba(var(--gold-rgb),0.30); color: rgba(255,255,255,0.92);">suspender</span>
            </div>
            <div style="margin-top: 0.35vw; font-size: 0.95vw; line-height: 1.35; color: rgba(255,255,255,0.78);">CK &gt;10× LSN, fraqueza</div>
          </div>

          <div style="padding: 0.85vw 0.9vw; border-radius: 0.9vw; background: rgba(255,255,255,0.06); border: 1px solid rgba(255,255,255,0.12);">
            <div style="display:flex; justify-content:space-between; gap: 0.8vw; align-items:baseline;">
              <div style="font-size: 1.05vw; font-weight: 900; color: rgba(255,255,255,0.95);">Rabdomiólise (raríssimo)</div>
              <span class="chip" style="background: rgba(var(--danger-rgb),0.20); border-color: rgba(var(--danger-rgb),0.28); color: rgba(255,255,255,0.92);">não insistir</span>
            </div>
            <div style="margin-top: 0.35vw; font-size: 0.95vw; line-height: 1.35; color: rgba(255,255,255,0.78);">CK &gt;40× LSN, mioglobinúria</div>
          </div>
        </div>
      </div>

      <div class="card" style="padding: 1.35vw; border: 2px solid rgba(var(--gold-rgb),0.45); background: rgba(var(--gold-rgb),0.08);">
        <div class="small-title" style="color: rgba(var(--navy-rgb),0.75);">Pergunta clínica (PICO)</div>

        <p style="margin: 0.9vw 0 0 0; font-family: var(--font-serif); font-size: 1.18vw; line-height: 1.45; color: var(--navy);">
          Em pacientes com <b>intolerância confirmada</b> e alto risco CV, <b>bempedoic acid</b> (vs placebo) reduz <b>MACE</b>?
        </p>

        <div style="margin-top: 0.95vw; padding-top: 0.95vw; border-top: 1px solid rgba(var(--gold-rgb),0.45);">
          <div style="display:flex; flex-wrap: wrap; gap: 0.55vw;">
            <span class="chip chip--muted">Comparador prático: ezetimiba</span>
            <span class="chip chip--muted">Alternativa: PCSK9i (acesso/custo)</span>
          </div>
        </div>
      </div>

    </div>
  </div>

  <!-- FOOTER -->
  <div style="margin-top: auto; padding-top: 1vw; border-top: 1px solid var(--border);">
    <p class="ref" style="margin: 0;">
      <b>Fontes:</b> Thompson PD et al. <i>J Am Coll Cardiol</i> 2016;67(20):2395–2410 &nbsp;|&nbsp; Stroes ES et al. EAS Consensus. <i>Eur Heart J</i> 2015;36:1012–1022.
    </p>
  </div>

</section>
